Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma

By Yang Shih-Hung  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 325-327

Springer Publishing Company

Access to resources Recommend Favorite

Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma

By Stroffolini T.   Andriani A.   Bibas M.   Barlattani A.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 48-49

Springer Publishing Company

Access to resources Recommend Favorite

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP

By Dai Ming-Shen   Chao Tsu-Yi   Kao Woei-Yau   Shyu Rong-Yaun   Liu Tan-Mei  

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 769-774

Springer Publishing Company

Access to resources Recommend Favorite

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

By He Yi-Fu  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 481-485

Springer Publishing Company

Access to resources Recommend Favorite

Differential Regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in Hepatitis C Virus-associated non-Hodgkin's Lymphoma

By Yao Zhi Q.   Ni Lei   Zhang Ying   Ma Cheng J.   Zhang Chun L.   Dong Zhi P.   Frazier Ashley D.   Wu Xiao Y.   Thayer Penny   Borthwick Thomas   Chen Xin Y.   Moorman Jonathan P.  

Immunological Investigations, Vol. 40, Iss. 3, 2011-01 ,pp. : 243-264

Informa Healthcare

Access to resources Recommend Favorite